Algert Global LLC Amicus Therapeutics, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

A detailed history of Algert Global LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 259,160 shares of FOLD stock, worth $2.56 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
259,160
Previous 88,585 192.56%
Holding current value
$2.56 Million
Previous $879,000 214.9%
% of portfolio
0.07%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$9.55 - $12.09 $1.63 Million - $2.06 Million
170,575 Added 192.56%
259,160 $2.77 Million
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $800,808 - $1.04 Million
88,585 New
88,585 $879,000
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $1.84 Million - $2.68 Million
184,540 New
184,540 $2.62 Million
Q1 2023

May 12, 2023
BUY
$10.91 - $13.54 $568,116 - $705,068
52,073 Added 18.71%
330,425 $3.66 Million
Q4 2022

Feb 13, 2023
BUY
$9.89 - $12.7 $617,531 - $792,988
62,440 Added 28.92%
278,352 $3.4 Million
Q3 2022

Nov 15, 2022
BUY
$9.82 - $12.75 $1.61 Million - $2.1 Million
164,364 Added 318.86%
215,912 $2.25 Million
Q2 2022

Aug 15, 2022
SELL
$6.23 - $11.12 $643,253 - $1.15 Million
-103,251 Reduced 66.7%
51,548 $554,000
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $857,429 - $1.36 Million
108,673 Added 235.6%
154,799 $1.47 Million
Q4 2021

Feb 14, 2022
BUY
$9.82 - $12.44 $62,170 - $78,757
6,331 Added 15.91%
46,126 $533,000
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $179,528 - $243,205
20,541 Added 106.68%
39,795 $380,000
Q2 2021

Aug 13, 2021
SELL
$8.71 - $10.72 $242,782 - $298,809
-27,874 Reduced 59.15%
19,254 $186,000
Q1 2021

May 14, 2021
SELL
$9.2 - $23.86 $104,327 - $270,572
-11,340 Reduced 19.4%
47,128 $466,000
Q4 2020

Feb 12, 2021
BUY
$13.47 - $24.89 $362,881 - $670,536
26,940 Added 85.45%
58,468 $1.35 Million
Q3 2020

Nov 16, 2020
SELL
$12.89 - $15.89 $587,139 - $723,789
-45,550 Reduced 59.1%
31,528 $445,000
Q2 2020

Aug 12, 2020
SELL
$8.86 - $15.69 $191,349 - $338,856
-21,597 Reduced 21.89%
77,078 $1.16 Million
Q1 2020

May 13, 2020
BUY
$6.63 - $11.16 $654,215 - $1.1 Million
98,675 New
98,675 $912,000

Others Institutions Holding FOLD

# of Institutions
313
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email